Overview
- Adams said Kaiser Permanente of Northern California approved Pluvicto but failed to schedule the brief IV infusion, adding that he is declining fast.
- Trump shared Adams’ post and wrote “On it,” while HHS Secretary Robert F. Kennedy Jr. asked how to reach Adams to assist.
- White House deputy chief of staff Dan Scavino said officials, including CMS administrator Mehmet Oz, were already tracking the case.
- Kaiser said Adams’ oncology team is working with him on next steps and noted it has treated more than 150 Northern California patients with Pluvicto since the FDA’s 2022 approval.
- By Monday, Adams posted that he was “so grateful” and said he is “getting what I need now,” though it remains unclear whether an infusion appointment has been set.